Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of the Literature.
Maharjan D, Collins K, Hou T, Umphress B, Robertson SE, Segura S.
Int J Gynecol Pathol. 2025 Mar 1;44(2):193-197. doi: 10.1097/PGP.0000000000001070. Epub 2024 Sep 10.
Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen Y, Wang J, Liu Y, Chen P, Wu X, Wen J.
Oncol Rep. 2015 Jun;33(6):2915-23. doi: 10.3892/or.2015.3937. Epub 2015 Apr 28.
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA.
J Natl Cancer Inst. 2019 Jan 1;111(1):60-68. doi: 10.1093/jnci/djy071.
Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG, Vosmikova H, Laco J.
Int J Gynecol Pathol. 2020 Jan;39(1):84-92. doi: 10.1097/PGP.0000000000000573.
High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment.
Vivod G, Merlo S, Kovacevic N.
Curr Oncol. 2024 Apr 2;31(4):1920-1935. doi: 10.3390/curroncol31040144.
Effect of ubiquitin-specific proteinase 43 on ovarian serous adenocarcinoma and its clinical significance.
Li Q, Li W, Wang J, Shi W, Wang T.
J Obstet Gynaecol. 2024 Dec;44(1):2361862. doi: 10.1080/01443615.2024.2361862. Epub 2024 Jun 25.
Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous Ovarian Adenocarcinoma.
Kutilin DS, Tsandekova MR, Porkhanova NV.
Bull Exp Biol Med. 2021 Jan;170(3):332-339. doi: 10.1007/s10517-021-05062-1. Epub 2021 Jan 16.
Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Carcinoma.
Kim H, Bae GE, Jung YY, Kim HS.
In Vivo. 2021 Nov-Dec;35(6):3613-3622. doi: 10.21873/invivo.12667.
MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma.
Li HM, Qiang JW, Xia GL, Zhao SH, Ma FH, Cai SQ, Feng F, Fu AY.
J Ovarian Res. 2015 Apr 30;8:26. doi: 10.1186/s13048-015-0154-2.
High expression of herpesvirus entry mediator (HVEM) in ovarian serous adenocarcinoma tissue.
Fang Y, Ye L, Zhang T, He QZ, Zhu JL.
J BUON. 2017 Jan-Feb;22(1):80-86.
